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Regional ischemia in hypertrophic Langendorff-perfused
rat hearts
J. F. ASHRUF,1 C. INCE,2 AND H. A. BRUINING1
1Department of Surgery, Erasmus University of Rotterdam, 3015 GD Rotterdam; and
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Ashruf, J. F., C. Ince, and H. A. Bruining. Regional
ischemia in hypertrophic Langendorff-perfused rat hearts.
Am. J. Physiol. 277 (Heart Circ. Physiol. 46): H1532–H1539,
1999.—Myocardial hypertrophy decreases the muscle mass-
to-vascularization ratio, thereby changing myocardial perfu-
sion. The effect of these changes on myocardial oxygenation in
hypertrophic Langendorff-perfused rat hearts was measured
using epimyocardial NADH videofluorimetry, whereby isch-
emic myocardium displays a high fluorescence intensity.
Hypertrophic hearts, in contrast to control hearts, developed
ischemic areas during oxygen-saturated Langendorff perfu-
sion. Reoxygenation of control hearts after a hypoxic episode
resulted in a swift decrease of fluorescence in a heterogeneous
pattern of small, evenly dispersed, highly fluorescent patches.
Identical patterns could be evoked by occluding capillaries
with microspheres 5.9 µm in diameter. Ten seconds after
reoxygenation there were no more dysoxic areas, whereas
reoxygenation in hypertrophic hearts showed larger ischemic
areas that took significantly longer to return to normoxic
fluorescence intensities. Hypothesizing that the larger areas
originate at a vascular level proximal to the capillary net-
work, we induced hypoxic patterns by embolizing control
hearts with microspheres 9.8 and 15 µm in diameter. The
frequency distribution histograms of these dysoxic surface
areas matched those of hypertrophic hearts and differed
significantly from those of hearts embolized with 5.9-µm
microspheres. These results suggest the existence of areas in
hypertrophic Langendorff-perfused hearts with suboptimal
vascularization originating at the arteriolar and/or arterial
level.
hypertrophy; hypoperfusion; reduced nicotinamide adenine
dinucleotide fluorescence; microspheres; microcirculation
HYPERTROPHIC MYOCARDIUM is more susceptible to ische-
mic damage than normal myocardium because of,
among other factors, changes in its vascularization (7,
21). Morphological studies of vasculature in hypertro-
phic myocardium have demonstrated profound changes
in anatomy and function. In hypertrophic myocardium,
capillary density and coronary vascular reserve de-
crease, whereas minimal coronary vascular resistance
increases (11, 19, 20). Hypertrophy also increases diffu-
sion distances from capillaries to myocytes (22, 24).
These changes are not distributed evenly throughout
the myocardium, resulting in a diversion of coronary
flow from subendocardial to subepicardial layers (1, 8).
Many studies have shown this transmural redistribu-
tion of coronary flow in hypertrophy with changes in
the heterogeneity of flow and vascularization between
subsequent transmural myocardial layers (1, 22, 23).
Less is known, however, of the effect of hypertrophy on
the local distribution of oxygen through the myocardial
microcirculation. For instance, measurements of local
oxygen consumption and supply did not show any
difference between normal and hypertrophic in situ
hearts at rest (25) and during stress (5, 28), whereas a
significant functional impairment in hypertrophic
hearts was demonstrated. An explanation may be that
these hearts were blood-perfused in situ hearts with a
physiological oxygen supply-to-demand ratio as com-
pared with Langendorff-perfused rat hearts, which are
known to have a marginal oxygen supply, resulting in
the development of ischemia when the oxygen supply-to-
demand ratio decreases slightly (13). In a previous
study we found that hypertrophic Langendorff-per-
fused hearts spontaneously developed hypoxic areas
that could be alleviated by factors influencing oxygen
free radical concentrations through the addition of fatty
acids or superoxide dismutase to the perfusate (12).
The purpose of the present study was to investigate
the nature of the spatial distribution of the hypoxic
state in myocardial regions and the vascular level at
which perfusion is disturbed in myocardial hypertro-
phy by using epicardial NADH videofluorescence to
monitor the mitochondrial energy state (15). Measure-
ment of the mitochondrial autofluorescence of reduced
pyridine nucleotide (NADH) of the epimyocardium
allows the identification of hypoxic regions because
NADH (which accumulates during hypoxia) fluoresces
when exited with ultraviolet (UV) light and oxidized
NAD1 does not (6). There is also a fairly linear relation-
ship between the oxygen concentration available to
mitochondria and the NADH fluorescence intensity, as
has been shown in isolated mitochondria (6). In this
way the local mitochondrial energy state of the myocar-
dium can be visualized (2). In normal Langendorff-
perfused rat hearts a stepwise transition from anoxic to
normoxic perfusion was accompanied by a transition
from high epicardial NADH fluorescence intensity to
low fluorescence intensity with a reproducible patchy
pattern of high-fluorescence anoxic areas lagging be-
hind low-fluorescence normoxic areas (15). These areas
are microcirculatory weak units, because in a given
heart they were always at the same location and were
the first to become hypoxic during tachycardia (2, 15).
These weak units were also the first to become hypoxic
during inhibition of nitric oxide synthesis in endotox-
emic rat hearts (4) and could be the cause of shunting
pathways during sepsis (17). Hypoxic areas of identical
size and pattern could also be elicited by embolization
of the capillaries by microspheres whose diameter
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corresponded to the capillary diameter (5.9 µm),
whereas embolization of arterioles and arteries by
larger microspheres produced larger hypoxic areas not
corresponding to the heterogeneous areas seen during
recovery from hypoxia (15). We hypothesized that in
hypertrophic myocardium this pattern would be al-
tered because of the formerly mentioned circulatory
changes, resulting in suboptimally perfused myocar-
dial regions. Furthermore, the size of the hypoxic areas
in hypertrophic myocardium could elucidate at which
vascular level the impaired perfusion originated. In
this study we analyzed the anatomic substrate respon-
sible for the appearance of these dysoxic areas in
hypertrophic hearts. Preliminary results were reported
elsewhere (3).
MATERIALS AND METHODS
Experimental setup. Male Wistar rats weighing 200–250 g
were operated on, undergoing subdiaphragmatic and suprare-
nal aortic narrowing to induce left ventricular hypertrophy
(18), and were killed 6 wk later when they weighed 250–300
g. For control measurements, rats of similar weight were
used. Hearts were removed and perfused according to Langen-
dorff and paced via aortic and right ventricular leads. Mean
coronary flow rates (in ml·min21 ·g ventricle wet wt21) were
measured with an electromagnetic flow probe (Skalar-
Medical, Delft, The Netherlands) placed immediately proxi-
mal to the aortic cannula. Perfusion pressure was measured
with a pressure transducer (Hewlett-Packard 8805B corner
amplifier) connected to the aortic cannula. The perfusate was
a modified Tyrode solution (128 mM NaCl, 4.7 mM KCl, 1 mM
MgCl2, 0.4 mM NaH2PO4, 1.2 mM Na2SO4, 20.2 mM NaHCO3,
and 1.3 mM CaCl2) containing 11.0 mM glucose. Perfusate
temperature was kept at 37°C and equilibrated with either
95% O2-5% CO2 or 95% N2-5% CO2. Perfusate pH was kept
between 7.35 and 7.45. Hearts were paced at 5 Hz. The left
ventricle was cannulated and communicated with the atmo-
sphere via its apex to prevent generation of left ventricular
pressure (2). In some experiments 10 µM nitroprusside, an
endothelium-independent vasodilator, was added to the per-
fusate. In other experiments microspheres (Polyscience, War-
rington, PA) of different diameters were infused into the
coronary circulation. When indicated, the oxygen-saturated
perfusate contained 10% (vol/vol) fluorocarbon F-43 emulsion
(an artificial oxygen carrier) and 1% (wt/vol) fatty acid-free
BSA. The stock fluorocarbon emulsion was obtained by
sonifying 24 ml of F-43 and 5.6 g of pluronic F-68 in 150 ml of
water at 4°C for 1 h under continuous bubbling of CO2
through the solution (9). Chemicals were obtained from
Merck (Darmstadt, Germany).
Fluorescence measurements. The NADH videofluorimeter
used has been described previously (2, 15). The UV light from
a 100-W mercury arc lamp (Olympus, Tokyo, Japan) was
selected by means of a UG-1 barrier filter, centered around
365 nm, to provide the UV light needed for NADH excitation.
The NADH fluorescence signal was selected by means of a
band-pass filter centered around 470 6 20 nm and was placed
in front of the camera. An image-intensified video camera
(MXRi, Adimec, Eindhoven, The Netherlands) with a Micro-
Nikkor 105-mm macrolens was used to detect NADH fluores-
cence images of the left ventricle of the heart. To enable
correction of images for changes in the sensitivity of the
videofluorimeter and fluctuations in the intensity of the light
source, a small piece of uranyl calibration glass was placed
next to the heart within the excitation field. Images were
recorded on a video recorder and were computer analyzed
off-line with the use of image-processing software (TCLImage,
Multihouse, Amsterdam, The Netherlands). Arbitrary units
of NADH fluorescence intensities relative to uranyl fluores-
cence intensity are expressed as percentages, where 100% is
taken as the intensity of epicardial NADH fluorescence at the
end of a 2-min period of perfusion with nitrogen-saturated
medium.
Experimental protocols. Hearts were allowed at least 15
min of stabilization after the start of the Langendorff perfu-
sion at a perfusion pressure of 80 mmHg with oxygen-
saturated perfusate before the following experimental proto-
cols were performed.
To examine the fluorescence patterns in hypertrophic left
ventricle during oxygen-saturated Langendorff perfusion and
posthypoxic recovery, protocol 1 was carried out. After the
stabilization of flow during normoxic perfusion, perfusion was
switched to nitrogen-saturated perfusate for 2 min and then
restored to normoxic perfusion. Because large ischemic areas
already existed during normoxic perfusion at a perfusion
pressure of 80 mmHg, perfusion pressure was increased to
100 and then 120 mmHg for 5 min each to increase coronary
flow and oxygen transport. This did not cause the ischemic
areas to disappear, and perfusion pressure was restored to 80
mmHg. Finally, to ascertain that the ischemic areas already
visible at the beginning of perfusion were reversible [and did
not represent infarcted (fibrotic) highly fluorescent myocar-
dium (16)], oxygen transport to the myocardium was increased
by either adding 10 µM nitroprusside to the oxygen-saturated
perfusate or switching perfusion to fluorocarbon-containing
oxygen-saturated medium.
Protocol 2 was performed to examine fluorescence patterns
in control left ventricle during posthypoxic recovery and
progressive hypoperfusion. After the stabilization of flow
during normoxic perfusion, perfusion pressure was decreased
to 60 mmHg to obtain coronary flows comparable between
control hearts and hypertrophic hearts. As in protocol 1,
control hearts were subjected to a 2-min period of nitrogen-
saturated perfusion, after which perfusion was restored to
oxygen-saturated perfusate. Hereafter, each heart was sub-
jected to stepwise reduction of perfusion pressure from 60
mmHg to 10 mmHg in steps of 10 mmHg, with each step
lasting 3.5 min.
To determine which vascular level determined the appear-
ance of the ischemic areas in hypertrophic hearts, control
hearts were embolized with microspheres of different diam-
eters in protocol 3. The frequency distributions of ischemic
surface areas in embolized control hearts were compared with
those of hypertrophic hearts. After the stabilization of flow in
control hearts, heterogeneous fluorescence patterns were
elicited by switching perfusion from oxygen-saturated perfus-
ate to nitrogen-saturated perfusate (for 2 min) and back.
When flow had returned to baseline values, microspheres
emulsified in Tyrode solution were infused at a rate of
500–1,000 microspheres/min into the coronary flow (15).
Microspheres had fixed diameters of 5.9, 9.8, and 15 µm. Each
heart was perfused with microspheres of one diameter, and
infusion was stopped when flow was decreased to ,75% of the
baseline value. The surfaces of the ischemic areas caused by
embolization in control hearts and the surfaces of ischemic
areas in hypertrophic hearts during normoxic perfusion were
measured in the fluorescence images and expressed in pixels
(1 pixel . 670 µm2 of myocardial surface). The transition from
a normoxic area to an ischemic area is characterized by a
small transitional zone (26) where fluorescence intensity
increases gradually from normoxic to hypoxic intensity. The
surface of an ischemic area was defined as the number of











pixels with a fluorescence intensity larger than or equal to the
intensity halfway between the intensity of the normoxic
surrounding area and the peak intensity of the ischemic area.
Relative frequency distributions were calculated for six inter-
vals of surface areas (see Fig. 7), and the proportion of total
ischemic epicardial surface and the number of ischemic areas
were measured (see Fig. 8).
Data are presented as means 6 SE. Mean relative frequen-
cies of surface areas per interval were tested for differences
between groups using unpaired t-tests. Group means of other
data were also tested for differences, also using unpaired
t-tests. The criterion for significance was taken to be P , 0.05
for all comparisons.
RESULTS
Five hypertrophic Langendorff-perfused hearts (total
ventricle wet wt 1.6 6 0.2 g) were subjected to proto-
col 1. Hearts instantly developed ischemic areas, indi-
cated by patches of highly fluorescent myocardium
(Fig. 1A). These ischemic areas were stable in size and
time during the entire period of normoxic perfusion,
lasting up to 30 min. After stabilization, the perfusate
was switched to nitrogen-saturated medium for 2 min,
which caused an increase of coronary flow from 13.8 6
0.4 (at 2 min in Fig. 2A) to 24.4 6 0.4 ml·min21 ·g21 (at
4 min in Fig. 2A) and an increase of NADH fluorescence
intensity of the total epicardium from 32 6 3% (Fig. 1A;
at 2 min in Fig. 2B) to 100% (Fig. 1B; at 4 min in Fig.
2B). Restoration to oxygen-saturated perfusion de-
creased coronary flow and epicardial fluorescence inten-
sity (Figs. 1C and 2A). The decrease of NADH fluores-
cence intensity was spread in uneven patterns across
the epimyocardial surface with larger areas having a
high fluorescence intensity, persisting even after 20 s of
reperfusion (Fig. 1C). Eventually fluorescence inten-
sity decreased to the baseline level at the start of the
experiment; this took longer than 5 min. To increase
oxygen transport to the myocardium after coronary
flow had reached baseline levels, perfusion pressure
was increased to 100 and then 120 mmHg. Coronary
flow increased from 14.1 6 0.3 to 17.0 6 0.5 and then
19.8 6 0.7 ml·min21 ·g total ventricle wet wt21, respec-
tively, but this did not cause ischemic areas to disap-
pear (data not shown). Perfusion pressure was then
restored to 80 mmHg. The perfusate was switched to
oxygen-saturated medium containing nitroprusside to
increase oxygen transport by vasodilatation. Flow in-
creased from 13.5 6 0.5 to 27.8 6 1.2 ml·min21 ·g total
ventricle wet wt21, and ischemic areas completely
disappeared (Fig. 1D). To increase oxygen transport in
a different manner, in three additional hypertrophic
hearts (total ventricle wet wt 1.5 6 0.1 g) not subjected
to this protocol but which also displayed ischemic areas
on commencement of Langendorff perfusion, the perfus-
ate was switched from oxygen-saturated medium to
fluorocarbon-containing oxygen-saturated medium.
Flow decreased from 14.5 6 0.7 to 12.1 6 0.6 ml·min21·g
total ventricle wet wt21 (not significant), and the size of
ischemic areas dramatically decreased (Fig. 3).
Control hearts (n 5 5, total ventricle wet wt 1.1 6 0.1
g) were subjected to protocol 1, which differed from
protocol 2 (hypertrophic hearts) in that, at the start of
the protocol, perfusion pressure was decreased to 60
mmHg to obtain coronary flows comparable to those of
the hypertrophic hearts. Coronary flows of control
hearts 2 min before the start of nitrogen-saturated
perfusion did not differ significantly from those of
hypertrophic hearts (Fig. 2A). At the start of perfusion
there were no ischemic areas (Fig. 4A). When the
perfusate was switched from oxygen- to nitrogen-
saturated medium, NADH fluorescence homogeneously
increased over the entire epicardial surface (Figs. 2B
and 4B). Also, coronary flow increased from 14.3 6 0.8
(at 2 min in Fig. 2A) to 28.3 6 2.0 ml·min21 ·g21 (at 4
min in Fig. 2A). During reperfusion with oxygen-
saturated medium, NADH fluorescence rapidly de-
creased in a heterogeneous pattern (Fig. 4C) of small
areas with fluorescence intensities ranging from a low
(normoxic) to a high (hypoxic) fluorescence intensity, as
described previously (15). Ten seconds after reperfu-
sion, control hearts no longer displayed ischemic areas
(data not shown), whereas in hypertrophic hearts
postreperfusion ischemia persists much longer (com-
pare Fig. 1, A and C; 20 s after reperfusion the
hypertrophic hearts have ischemic areas that are still
larger than they were at the start of perfusion). This is
also shown in Fig. 2B; after reperfusion, mean NADH
fluorescence intensity decreases in both control and
hypertrophic hearts but remains significantly higher in
hypertrophic hearts for at least 2 min. Figure 2A also
shows that after reperfusion, coronary flow decreases
faster in hypertrophic hearts than in control hearts (for
instance, 1 min after reperfusion, coronary flow in the
hypertrophic hearts is 15.2 6 0.7 ml·min21·g21, whereas
in control hearts it is 24.1 6 1.0 ml·min21 ·g21).
These results suggest that Langendorff-perfused rat
hearts that are hypertrophic are hypoperfused, causing
ischemic areas to appear. To investigate whether hy-
poperfusion of control hearts causes similar ischemic
areas, perfusion pressure was decreased in a stepwise
manner from 60 to 10 mmHg, with each step lasting 3.5
min (protocol 2 continued) after flow returned to base-
line levels after the reperfusion experiment. Flow con-
Fig. 1. NADH fluorescence images of a hypertrophic
heart at the start of oxygen-saturated perfusion (A), at
the end of nitrogen-saturated perfusion (B), 20 s after
reoxygenation (C), and during perfusion with oxygen-
saturated nitroprusside-containing medium (D).











comitantly decreased (Fig. 5E) and stabilized in ,2
min after each drop in perfusion pressure. Ischemic
areas grew progressively larger during perfusion pres-
sures of #30 mmHg (Fig. 5, B–D). The highly fluores-
cent ischemic areas were identical in pattern to those
seen after switching from nitrogen- to oxygen-satu-
rated perfusion and were evenly distributed over the
epicardium (compare Figs. 4C and Fig. 5, B–D). In
these experiments, however, patterns with relatively
large ischemic areas coexisting with large normoxic
areas as seen in hypertrophic hearts did not appear.
To identify at which level of arteriolar and/or arterial
vasculature the ischemic areas originate in hypertro-
phic myocardium during oxygen-saturated perfusion,
control hearts were embolized with microspheres of
different diameters according to protocol 3; five hearts
were embolized with 5.9-µm microspheres, three with
9.8-µm microspheres, and three with 15-µm micro-
spheres. The larger the diameter, the larger the isch-
emic areas, as shown in Figs. 6 and 7. Figure 7 shows
the frequency distribution of ischemic surface areas of
hearts embolized with 5.9-, 9.8-, and 15-µm micro-
spheres and of the hypertrophic hearts of protocol 1.
The mean relative frequency distribution of ischemic
surface areas in hypertrophic hearts did not differ
significantly from those in control hearts embolized
with 9.8- and 15-µm microspheres (except for the
interval from 600 to 800 pixels, where there was a
significant difference between hypertrophic hearts and
control hearts embolized with 9.8-µm microspheres),
whereas it did differ significantly from the frequency
distribution of hearts embolized with 5.9-µm micro-
spheres (Fig. 7). The proportion of ischemic epicardium
and number of ischemic areas of hearts embolized with
the different microspheres and of hypertrophic hearts
are shown in Fig. 8.
DISCUSSION
Earlier work identified hypoperfused ischemic areas
in hypertrophic Langendorff-perfused hearts (12). The
present study was performed to locate the vascular
level at which these hypoperfused areas originate. The
main findings of this study were that the ischemic
areas in hypertrophic Langendorff-perfused rat hearts
were significantly larger than ischemic areas evoked by
capillary embolization or by normoxic recovery from
nitrogen-saturated perfusion. The ischemic surface ar-
eas had a frequency distribution closely resembling
that of normal hearts embolized at the arteriolar and/or
Fig. 2. A: coronary flow changes in rat hearts during stepwise
changes in oxygenation. Thick line, mean coronary flow of control
heart during protocol 2 (n 5 5); thin line, mean coronary flow of
hypertrophic heart during protocol 1 (n 5 5); dashed lines, 6SE.
Horizontal bar indicates period of statistically significant (P , 0.05)
difference in coronary flow between control and hypertrophic hearts.
B: mean relative NADH fluorescence in rat hearts during stepwise
changes in oxygenation. k, NADH fluorescence of control heart
during protocol 2; r, NADH fluorescence of hypertrophic heart
during protocol 1. Values are means 6 SE. Steps: 0–2 min, perfusion
with oxygen-saturated medium; 2–4 min, perfusion with nitrogen-
saturated medium; 4–6 min, reoxygenation with oxygen-saturated
medium. *Statistically significant (P , 0.05) difference in mean
relative fluorescence between control and hypertrophic hearts.
Fig. 3. NADH fluorescence images of a hypertrophic heart during
perfusion with oxygen-saturated medium containing no fluorocar-
bons (A) and 3 min after perfusion with oxygen-saturated medium
containing fluorocarbons (B).
Fig. 4. NADH fluorescence images of a control heart (protocol 2) at
the start of oxygen-saturated perfusion (A), at the end of nitrogen-
saturated perfusion (B), and 5 s after reoxygenation with oxygen-
saturated medium (C).











arterial level, suggesting the existence of hypoperfu-
sion originating at the arteriolar and/or arterial level.
In this study we used epicardial NADH fluorescence
to measure epicardial ischemia. The definition of ische-
mia in terms of fluorescence intensity requires further
elaboration. Anoxia induced in Langendorff-perfused
rat hearts leads to a four- to fivefold increase in NADH
fluorescence intensity relative to the normoxic NADH
fluorescence intensity (15). In this study we measured
the surface areas of ischemic epicardial zones with a
NADH fluorescence intensity greater than the inten-
sity halfway between the intensities of the normoxic
surrounding area and those of the ischemic epicardial
zones. The NADH fluorescence intensities of the ische-
mic zones were at least threefold greater than the
NADH fluorescence intensities of normoxic epicar-
dium. Because fluorescence measurements were made
in beating hearts, we minimized motion artifacts by
selecting images from the hearts in identical positions
in the cardiac cycle (2).
The NADH fluorescence intensity is also dependent
on the amount of work output and the mitochondrial
state (2, 6). High work output induces a decrease of the
basal normoxic fluorescence intensity. The left ventricle
was cannulated and communicated with the atmo-
sphere in all experiments to prevent the development of
left ventricular pressure buildup, resulting in similar
mitochondrial states in both hypertrophic and control
hearts. This prevented confounding of the fluorescence
measurements by variations in work output (2). Still,
differences in ADP substrate levels between control
hearts and hypertrophic hearts could cause differences
in NADH fluorescence intensities. However, as can be
deduced from Refs. 2 and 6, differences in fluorescence
induced by ADP substrate-level variation are not as
large as differences induced by ischemia.
Another factor influencing NADH fluorescence inten-
sity is substrate availability. It was shown earlier that
the normoxic NADH fluorescence intensity is depen-
dent on the substrate: pyruvate increases normoxic
fluorescence the most, oleate less, and glucose even less
(2, 12). In this study, however, all experiments were
performed with 5.5 mM glucose. Normoxic fluorescence
intensity did not differ between hypertrophic and con-
trol hearts (data not shown), and highly fluorescent
areas in hypertrophic hearts disappeared on improve-
ment of myocardial oxygenation (Figs. 1D and 3B),
thereby excluding the confounding of NADH fluores-
cence measurements by differences in substrate avail-
ability between control and hypertrophic hearts.
Fig. 5. NADH fluorescence images of a control heart
during oxygen-saturated perfusion (protocol 2) at a
perfusion pressure of 40 (A), 30 (B), 20 (C), and 10
mmHg (D). E: coronary flow in control hearts (n 5 5)
during stepwise decreases of perfusion pressure.
Fig. 6. NADH fluorescence images of control hearts
during embolization of vasculature with microspheres
of different diameters: 5.9 µm (A), 9.8 µm (B and C), and
15 µm (D).











In this study we decreased perfusion pressure in
control hearts to obtain comparable coronary flow rates
between control and hypertrophic hearts. This did not
result in qualitatively different NADH fluorescence
patterns in control hearts (data not shown). We did not
increase perfusion pressure in hypertrophic hearts to
this end, because this would have resulted in nonphysi-
ologically high perfusion pressures in hypertrophic
hearts. In all experiments in this study the left ventricu-
lar cavity communicated with the atmosphere via a
cannula inserted through the apex of the left ventricle
to ensure the lowest possible cardiac work output in all
hearts, thereby reducing the confounding of NADH
fluorescence measurements by differences in oxygen
consumption (2).
Normal rat hearts Langendorff perfused with oxygen-
saturated medium continuously release lactate in their
effluent, indicating that they are borderline aerobic
(13). However, epicardial NADH fluorescence measure-
ments under these circumstances do not reveal dysoxic
areas (Fig. 4A) (15). Hypertrophic hearts are known to
have a decreased myocardium-to-vascularization ratio
(8, 22). Because of this less optimal vascularization, we
expected hypertrophic Langendorff-perfused hearts to
develop highly NADH-fluorescent ischemic areas dur-
ing normoxic perfusion, as shown earlier (Fig. 1A) (3,
12). That study had suggested that the development of
ischemia was related to the production of oxygen free
radicals and acidosis in hypoperfused areas of hypertro-
phic hearts because of the finding that these ischemic
areas could be relieved by perfusion with superoxide
dismutase, a scavenger of oxygen free radicals, or by
perfusion with fatty acids, resulting in a protection
from acidosis-initiated loss of capillary flow. Steenber-
gen et al. (26) also observed the development of rela-
tively large ischemic areas induced by acidosis in
normal hearts and suggested that acidosis-induced
coronary (arteriolar and/or arterial) changes were re-
sponsible.
Ischemic areas in hypertrophic hearts were elicited
at flow rates that did not cause local ischemia in control
hearts, suggesting the existence of local hypoperfused
areas in hypertrophic Langendorff-perfused rat hearts.
To ascertain that these highly fluorescent areas were
still viable areas of myocardium and were dysoxic
because of impaired oxygenation, oxygen transport was
increased in several ways. Adding fluorocarbons or
nitroprusside to the perfusate resulted in either com-
plete disappearance (nitroprusside, Fig. 1A) or signifi-
cant reduction of ischemia (fluorocarbons, Fig. 3). Fur-
thermore, histological analysis in formaldehyde-fixed
hypertrophic hearts stained with hematoxylin-eosin
revealed no evidence of infarction (data not shown).
Increasing coronary flow by increasing perfusion pres-
sure, however, did not produce a significant decrease in
ischemic areas (data not shown) in hypertrophic hearts.
An explanation for this observation could be that
because of the increase in coronary perfusion pressure,
oxygen consumption increases, thereby more or less
keeping the ratio between oxygen supply and demand
unchanged (10). Alternatively, enhancing flow by in-
creasing perfusion pressure could only affect shunting
flow, thereby leaving the hypoperfused areas still dys-
oxic.
In a previous study (15) we had shown with NADH
fluorescence measurements in normal hearts that occlu-
sion of vessels of increasing diameter induced patchy
ischemic areas of increasing surface area. Further-
more, normoxic recovery in control hearts from perfu-
sion with nitrogen-saturated medium was accompa-
nied by a heterogeneous NADH fluorescence pattern
with small, highly fluorescent patches lagging behind
areas with a much faster decrease of fluorescence.
These ischemic areas were shown to be microcircula-
Fig. 7. Frequency distribution histogram of ischemic surface area (1
pixel 5 670 µm2) in hearts embolized with microspheres 5.9 (n 5 5),
9.8 (n 5 3), and 15 µm (n 5 3) in diameter and in hypertrophic hearts
(n 5 5). Columns represent mean frequency and bars represent SE.
*Statistically significant (P , 0.05) different from 5.9-µm micro-
spheres.
Fig. 8. Proportion of ischemic epicardium (open bars) and number of
ischemic areas (filled bars) of hearts embolized with microspheres 5.9
(n 5 5), 9.8 (n 5 3), and 15 µm (n 5 3) in diameter and in hypertrophic
(hyp) hearts (n 5 5). Columns represent mean values and bars
represent SE.











tory units originating at the capillary level, which were
the last to be reoxygenated during reperfusion and
could also be elicited by occluding capillaries with
microspheres 5.9 µm in diameter (Fig. 6A) (15). A
recent histological study by Vetterlein et al. (27) in
normal rat hearts in vivo found that tissue located
within the capillary bed in proximity to the draining
venule is more prone to the development of hypoxia in
critical oxygen supply conditions. Hypoxia develops
during hypoperfusion because of a combination of dis-
turbances of perfusion in feeding areas of arterioles and
the loss of oxygen lengthwise along capillaries. Appar-
ently the microcirculatory units described by Ince et al.
(15) are located in capillary beds close to venules.
Ischemic areas in hypertrophic hearts at the start of
perfusion are significantly larger than those elicited by
capillary occlusion in normal hearts (compare Figs. 1A
and 6A), suggesting that they originate at a vascular
level proximal to the capillaries. This is also supported
by the finding that the embolization of increasingly
larger vessels (protocol 3) produces increasingly larger
ischemic areas that resemble those of hypertrophic
hearts (compare Figs. 6, B–D, and 1A). One could
argue, taking into account the study of Vetterlein et al.
(27), that in hypertrophy the disturbances of perfusion
of certain individual arterioles predominate over the
loss of oxygen lengthwise along capillaries, thereby
inducing larger ischemic areas. Another argument in
favor of this hypothesis is the close resemblance of the
frequency distribution histogram of ischemic surface
areas of hypertrophic hearts to that of control hearts
with embolized arterioles and/or arteries (Fig. 7).
Reperfusion with oxygen-saturated medium after
nitrogen-saturated perfusion in hypertrophic hearts
revealed a significantly different fluorescence pattern
from that of control hearts. Mean fluorescence intensity
decreased significantly slower with, 1 min after reperfu-
sion, a decline in mean fluorescence intensity of 52 6
2% in hypertrophic hearts compared with 40 6 2% in
control hearts (Fig. 2B). This was accompanied by a
significantly faster decrease of flow and thus less
oxygen transport after reperfusion in hypertrophic
hearts (15.2 6 0.7 ml·min21 ·g21 1 min after reperfu-
sion) compared with control hearts (24.1 6 1.0
ml·min21 ·g21 1 min after reperfusion) (Fig. 2B). Peak
flow during nitrogen-saturated perfusion was signifi-
cantly higher in control hearts compared with that in
hypertrophic hearts (Fig. 2B). These findings indicate a
decreased coronary flow reserve in hypertrophic hearts,
as was found in earlier studies (11, 19, 20). The
accompanying fluorescence images during the reperfu-
sion phase show the persistence of larger ischemic
areas (Fig. 1C) with high fluorescence even 20 s after
reperfusion, whereas in control hearts fluorescence
images reveal no ischemia even before that time. The
ischemic areas persisting in hypertrophic hearts after
reperfusion are also larger than those in control hearts
(compare Figs. 1C and 4C) and resemble those after
occlusion of arterioles and/or arteries with micro-
spheres (Fig. 6). This finding suggests the existence of
hypoperfused areas of myocardium in hypertrophy,
originating at the arteriolar and/or arterial level. To
examine the effect of hypoperfusion on control hearts,
perfusion pressure was progressively decreased (proto-
col 2). This induced ischemic areas that match the
pattern elicited by occluding capillaries (15) and are
much smaller in size than the dysoxic areas seen in
hypertrophic hearts. We were never able to induce
patterns of ischemia in control hearts resembling those
seen in the hypertrophic hearts. Apparently hypertro-
phy produced by the method used in this study induces
changes in arteriolar and/or arterial vascular control
that result in ischemia of myocardial areas during
suboptimal coronary perfusion. Earlier work (12, 14)
has shown that a possible mechanism accounting for
such an effect could be scavenging of nitric oxide
(endothelium-derived relaxing factor) by increased oxy-
gen free radical production in ischemic myocardial
areas in hypertrophic hearts.
In conclusion, in this study we found that the pattern
of oxygen transport to the epimyocardium is profoundly
altered in hypertrophy. These changes are the result of
dysregulation of flow at the arteriolar and/or arterial
level. The areas with the slowest reoxygenation after
ischemia in hypertrophy are larger than the microcircu-
latory units described by Ince et al. (15) and have a
surface area distribution matching that of the ischemic
areas evoked by arteriolar and/or arterial embolization.
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